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Abstract
Background: The health information needs of developing countries increasingly include
population-based estimates determined by biological and physiological measures. Collection of data
on these biomarkers requires careful reassessment of ethical standards and procedures related to
issues of safety, informed consent, reporting, and referral policies. This paper reviews the survey
practices of health examination surveys that have been conducted in developed nations and
discusses their application to similar types of surveys proposed for developing countries.
Discussion: The paper contends that a unitary set of ethical principles should be followed for
surveys around the world that precludes the danger of creating double standards (and implicitly
lowers standards for work done in developing countries). Global ethical standards must, however,
be interpreted in the context of the unique historical and cultural context of the country in which
the work is being done. Factors that influence ethical considerations, such as the relationship
between investigators in developed and developing countries are also discussed.
Summary: The paper provides a set of conclusions reached through this discussion and
recommendations for the ethical use of biomarkers in populations-based surveys in developing
countries.
Introduction
The national health information needs of developing
countries are increasingly relying on the collection of bio-
logical and physiological measures [1-5]. The use of these
biomarkers in population-based surveys has led to a call
for a review of the ethical standards under which surveys
are conducted in less-developed nations [6]. Controver-
sies over clinical research conducted in developing coun-
tries have intensified the scrutiny of all research being
conducted in these settings [7]. This debate has reaffirmed
that the global human rights and medical ethical princi-
ples – including fidelity, truthfulness, confidentiality,
autonomy, and beneficence, – must be carefully reviewed
in the name of research, surveillance, monitoring, and
Published: 28 November 2005
Globalization and Health 2005, 1:16 doi:10.1186/1744-8603-1-16
Received: 06 April 2005
Accepted: 28 November 2005
This article is available from: http://www.globalizationandhealth.com/content/1/1/16
© 2005 Pappas and Hyder; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Globalization and Health 2005, 1:16 http://www.globalizationandhealth.com/content/1/1/16
Page 2 of 7
(page number not for citation purposes)
evaluation [8-10]. Ethical issues in population-based sur-
veys include informed safety, informed consent, confi-
dentiality, and reporting findings of testing. Globalization
of ethical principles must be interpreted within the partic-
ulars of national context in which the scientific study takes
place.
Development of rapid, low cost, diagnostic kits and port-
able, robust technology has made possible a new genera-
tion of population-based health surveys [11]. While
standards and safeguards for health interview surveys in
developing countries have been in place for a number of
years, the use of these new technologies adds a layer of
new ethical issues to health surveys. The ethical issues
raised by the collection of biomarkers in large-scale exam-
ination surveys, and standards for implementation have
been developed over the past four decades in national
population-based surveys done in developed countries
[12]. The purpose of this paper is to review the current eth-
ical practices and procedures used to guide survey work in
the developed world, and discuss the implication of such
practices for work in developing countries. The manu-
script refers to written documents on these issues and
draws upon health examination survey work of the
authors in the United States and in less developed coun-
tries [3,13].
The article appears in three sections. The first section lays
out the ethical principles that bind which are raised by
health examination surveys, and reviews current practices.
The use of these so called biomarkers has a long history in
the National Health and Nutrition Examination Survey
(NHANES) of the Centers for Disease Control and other
major epidemiological studies (Framingham, Alameda
county) [14,15]. These population-based health surveys
have dealt with the following types of ethical issues: safety
of the survey to subjects and workers in survey, obtaining
appropriate informed consent, confidentiality of informa-
tion collected in the survey, the reporting of findings of
the health examination to the participant, the use of
stored samples for research, and the provision of health
care as part of a survey. While ethical principles may be
global, implementation of those principles must be care-
ful considered within local contexts in which the health
examination survey takes place. In the second section
these ethical issues will be addressed as they relate to con-
ducting health examination surveys in less developed
countries. This section emphasizes situations in which
global standards have to be interpreted in a national or
local context. While the spirit of the standard may be
toward uniformity of procedures, implementation of sur-
veys must consider many local conditions. Implementa-
tion of global standards in resource poor settings has
created feedback and frequently challenges interpretation
of those standards. The final section is a set of recommen-
dations to be considered by national survey planners and
donor agencies. While guidelines for health examination
surveys have been developed over a long period in the US
and Europe, those standards are under continued review
as science and practice evolve. The globalization of stand-
ards creates a challenge for those standards and for feed-
back onto standards as practiced in the resource rich
settings. Scientific advances and technological innova-
tions will continue to require review of standards and pro-
cedures of ethical conduct in health examination surveys.
I. Ethical Issues in Health Examination Surveys
This section reviews current practices being used in popu-
lation-based health surveys in the US and other countries.
Ethical practices for conducting health examinations sur-
veys have developed over the past four decades in the
United States and Europe related to safety, informed con-
sent, confidentiality, the reporting of findings, and long-
term sample storage in developed countries.
Safety issues in surveys consider consequences of collec-
tion of biological specimens and clinical testing for survey
participants and for data collectors. Biomarkers that are
minimally invasive are preferred (e.g., blood pressure
measurement, venous blood draw or urine collection).
Potentially dangerous tests (high intensity x-rays) have
usually been avoided. The use of minimally invasive, as
opposed to potentially dangerous procedures has impor-
tant implications to the risk/benefit ratio of the survey.
Safety standards for specimen collectors typically follow
clinical standards, and universal precautions for labora-
tory work have been adopted for field use.
Informed consent in health examination surveys has been
most frequently obtained in writing in developed nations.
Concerns about obtaining informed consent in special
populations have lead to accommodations or modified
procedures. In special populations – those with low levels
of literacy, different cultural traditions, a context of ineq-
uities, or where there is lack of health services, – informed
consent requires special consideration. An empirical liter-
ature has developed around the informed consent process
that raises concern about what participants understand or
remember about the consent process [16]. Judgment
about the appropriate level of effort to achieve informed
consent hinges on the risks and benefits of the survey. For
example, clearly worded, plain language, consent has
been deemed acceptable in surveys that convey minimal
to low risk and additional efforts to ensure complete com-
prehension of the purpose of the survey are not routinely
made.
Maintaining the confidentiality of information from sur-
vey participants is an important responsibility including
specific components, such as privacy during interviews
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(particularly around sensitive issues) and prevention of
inadvertent disclosure of identity, in analysis and data
release products. Concerns about confidentiality are
increased with biomarkers because they have the potential
for disclosing sensitive health information (e.g., disease
status, diabetes, HIV) leading to the misuse of this infor-
mation to profile individuals for social and health (insur-
ance) purposes. Legal standards to ensure confidentiality
have been adopted by governmental statistical agencies
[17].
The report of findings of individual laboratory or physio-
logical testing back to survey participants has historically
been done in three categories: standard reporting, routine
referral, and urgent referral. For example, normal levels of
blood pressure are reported to a subject in a standard way.
Elevated levels are reported and recommendations or fol-
low-up are made (referrals). Very high levels require
urgent referral; recommendations for action are made for
urgent action.
When investigators know, or can know, the identity of the
tested individual, they are required to report back to the
survey participant unless the consent process specified
otherwise. A person can consent that a result will not be
reported. Consent for not reporting has been considered
appropriate when the result of the test has little or poorly
understood significance to an individual's health. An
example of such a test was the assay for homocystene that
was done as part of the NHANES III. The laboratory
results for homocystene (that has been under study as a
risk factor for cardiovascular diseases) were not reported
to participants or their physicians because its physiologi-
cal or clinical significance was not known. Disease mark-
ers that have specific and potentially important health
consequences must always be reported to the individual if
the investigators can identify the individual and connect
the results of the test to that individual. An alternative that
has been used to address this issue is to "anonomize" the
samples by stripping the identifiers from the sample in a
way that makes it impossible to identify the survey partic-
ipant. In either case, the consent statement should make
clear whether the results will or will not be reported back
to participants.
Implementation of reporting also depends on a variety of
issues in a survey setting. Laboratory analyses that are not
performed in the field can not therefore be reported to
survey subjects at the time of the survey. Reporting at a
time after the initial field work can be a major challenge
for large scale surveys. It may also be desirable to share the
test results of an individual with a physician designated by
the survey participant. Reporting of results in a form that
is understandable to survey participants needs to be given
high priority when implemented. Reports of survey find-
ings to respondents may also include recommendations
of appropriate actions to be taken based on the findings.
Long-term storage of biological specimens collected in
population-based surveys has also been common and
raises other ethical concerns. Intention to store samples
should be included in the consent process. Frequently,
biological samples are stored without specific plans for
analysis and because testing may take place in the remote
future (years, even decades in the future) it cannot be
anticipated what tests it will be possible to conduct. It may
not be feasible to guarantee that the investigators could
reliably contact the person from whom the sample was
obtained.
Long term storage also has created the possibility for
genetic testing of samples collected in health examination
surveys. Standards are still involving the United States and
Europe [2]. The U.S. National Center for Health Statistics/
CDC/DHHS has approved of six protocols for genetic test-
ing of specimens collected as part of national populations
based household surveys (Health and Nutrition Examina-
tion Survey, NHANES, III) [18]. Consent in that survey
included broad permission for doing unplanned future
testing. Genetic tests had not been planned in the original
survey and was not specifically included in the consent.
With the extensive involvement of the IRB genetic testing
has begun under protocols that are considered explora-
tory. White cells were used to create over 8000 cell lines
for future genetic testing. The samples were "anono-
mized" so that no investigator, including those inside the
government can link the sample to the identity of a sam-
ple person. The on-going involvement of the NCHS IRB
will hopefully lead to creation of guidelines that may be
useful to other research settings.
II. Ethical Issues in Examination Surveys in Developing 
Countries
Universal standards may be the preferable approach to
guiding ethical conduct in surveys. Application of univer-
sal standards for ethical behavior in survey work in diverse
settings, however, requires careful consideration. Imple-
mentation of universal standards must consider cultural
settings, the health care delivery system of the country,
national legal frameworks, and the context of relation-
ships of investigators. This section will discuss ethical
issues raised by large-scale surveys in less developed coun-
tries that take biological and physiological measures.
Safety
International safety guidelines for the collection of bio-
logical and physiological measurements in surveys are the
norm for surveys conducted in less developed countries.
However, as with clinical practice, achieving these safety
guidelines is frequently difficult. Financial constraints in
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less developed countries often lead to clinical practices
that do not follow universal precautions. Lack of appro-
priate equipment and lack of training may leads to clinical
practices that put patients and health care workers at risk.
The clinical realities and experience of those who are
recruited to work in a health survey has consequences for
the implementation of safety guidelines. Safety guidelines
may be difficult to enforce in surveys with data collectors
drawn from clinical settings in which universal precau-
tions are not observed. Conflicts between international
advisors and country implementation staff may surface
around expenditures on equipment that is considered
unnecessary (latex gloves, disposal facilities). Clear con-
tractual agreements and supervision concerning safety
precautions are critical to the maintenance of safety stand-
ards.
Informed Consent
Many aspects of consent in examination surveys are simi-
lar to standards used in interview surveys in less devel-
oped countries. Standards for informed consent must be
adapted to cultural circumstances of the country in which
the surveys are conducted [19]. Verbal documented con-
sent is routinely used in settings of low literacy. In addi-
tion, cultural hierarchies may demand that approval is
obtained from the authority figures in the local context
(e.g., village elders, head of family). Translation problems
must be addressed; often many of the words needed to
explain the survey or a procedure do not translate into
local languages. The language of consent forms needs to
address the specific settings [20].
While coercion or inappropriate inducement is consid-
ered a violation of consent, financial incentives in devel-
oped country settings are a common practice [21].
Financial incentives are seen as a benefit to off-set lost
wages or the opportunity cost of time spent and effort
required for participation. The poverty in many countries
in which surveys are conducted, means that even the
smallest financial incentive may raise concern about
undue inducement to participate. Levels of financial
incentives for participation that is optimal without being
coercive is an empirical issue and must be established for
each setting.
Much of the contemporary controversy concerning ethics
of research done in less developed countries comes out of
clinically oriented research or drug efficacy trials. A dis-
tinction between experimental medical research and pop-
ulation-based health surveys helps clarify this discussion
of ethical guidelines. The risk inherent in clinical research
imposes a responsibility on the investigator for the well
being of human subjects. In contrast, surveys collect data
that describe health conditions of a population, or moni-
tor and evaluate population-based programs, and usually
are of minimal to low risk to human subjects. The risk of
population-based surveys is typically related to the bur-
den of questions, time, and sample of body fluid or tissue.
The difference between clinical studies and survey
research must be made clear to institutional review
boards. Including survey expertise on the membership of
an institutional review board is a good way to inform
these boards of the particular issues raised by survey
research.
While these ethical principles are well established, specific
procedures (e.g., wordings, verbal versus written, assur-
ance of comprehension) are very much tied to the specific
context of the research (complexity of the issues that
require consent, risks and benefits). Globally agreed upon
principles do not simplify the process of establishing
informed consent, and a sometimes lengthy consultation
is needed. However, complexities of informed consent are
common to resource rich and resource poor settings.
Confidentiality
The practical considerations related to confidentiality in
highly developed countries and the less developed coun-
tries may differ due to legal requirements, cultural issues,
and logistical constraints of the field research. The pri-
mary concern in the US and other developed countries is
that survey data is not used to disclose the identity of an
individual. Linkage of data systems and profiling (by
health care providers or insurers) presents concerns about
confidentiality in some settings. These sorts of concerns
are usually of low priority in less developed countries
because such risks are usually minimal or non-existent. In
many less developed countries people may not have spe-
cific addresses or standardized naming systems. These
conditions make it difficult to locate persons after the ini-
tial contact of a survey. In a practical sense this reality cre-
ates confidentiality and represents a safe guard. In
addition, stripping data of unique identifiers and data
control procedures are practices that help maintain confi-
dentiality and should be adopted universally [22].
Perhaps more critical in developing countries is privacy in
the field setting. Inadvertent disclosure of medical infor-
mation to family or neighbors during the data collection
process in the fields setting may be the major privacy
issues raised by field surveys in less developed countries.
Surveys conducted in less developed countries, particu-
larly in rural settings and in household surveys, make pri-
vacy in data collection a problem. Lack of privacy in
household survey settings has consequences on data qual-
ity and potential breaches of confidentiality. Communal
ways of living, large families, joint households and other
elements mean that people congregate quickly and indi-
vidual interviews are challenging. Training of field staff,
careful supervision, and quality control in field work
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related to privacy standards, are essential if privacy is to be
maintained in field settings.
Reporting Results
The reporting of findings of individual biological and
physical measurements to survey participants is deter-
mined, in part, by the nature of the parameter and the
clinical meaning (significance) of the parameter which
have universal implication. The social meaning of the dis-
ease or condition, the social context in which the report is
made and the nature of the health care delivery system,
which differ in countries, determine the appropriate man-
ner in which the reporting is done in less developed coun-
tries. Health examination surveys in less developed
countries have followed U.S. formats for reporting of test
results by reporting three categories: standard reporting,
routine referral, and urgent referral.
The social meanings of a report of findings in a particular
country context may influence the way that a report of a
finding is provided. For example leprosy or epilepsy in
stigmatized some cultures require additional considera-
tion in reporting. Privacy in reporting would need to be
heightened in these contexts.
The policy for reporting the findings of biological and
physiological measures to participants of population-
based surveys must also consider where the sample testing
actually takes place and how the reporting take place.
Measures taken in the field for which results are immedi-
ately available (blood pressure, rapid testing of blood)
can be reported as a routine part of field work. Specimens
collected in the field and tested in central laboratory
require other reporting procedures. Telephoning or mail-
ing reports of findings is the preferable policy but this may
not be feasible in many less developed countries. Long
distances, difficulty with travel, and difficulties with the
re-identification of sample persons make reporting of cen-
tralized testing very difficult.
An option exists to resolve the issues of difficulties raised
by having to return to households with test results done
after the initial visit. Obtaining consent not to report the
particular finding has been acceptable solution. In condi-
tions for which treatments are not available, reporting
may not be useful to the sample person (e.g., HSV2) and
may not be necessary. Nonetheless consent for not report-
ing has been recommended. Ethical review committees
must weigh the risks and benefits of these types of trade-
offs in surveys. The risks and benefits of participating in
the survey must be considered with a clear definition of
instances under which not reporting findings would be
considered appropriate.
The nature of the health care delivery system (that is, the
level of its development) is also critical to the report of
findings. Reporting a finding and recommending an
action that is not a realistic possibility for the patient is a
usual challenge that policy for report of findings must
face. Referral to the existing standard of care in the country
is the usual policy that has been proposed. More on the
issue of the responsibilities of survey researchers to pro-
vide services is discussed in the next section
Service and the Provision of Care
The finding of abnormal results of a biological or physio-
logical measure in a population-based survey may neces-
sitate referral. In less developed countries the policy for
referral must consider the types of services that are availa-
ble to the survey population. A referral to a poorly func-
tioning health care delivery system is problematic. The
notion that the prevailing standard of care in the country
is a sufficient referral has been challenged by some [23].
These sorts of challenges have been faced in the context of
clinical research in which investigators from countries
with higher levels of services have offered lower levels of
care. In clinical research, investigators may have a rela-
tionship with the study populations over a period of years
and subject the population to circumstances (drugs) that
are not risk free. The referral to prevailing standards of
care in the country may not be considered adequate. How-
ever, since population-based surveys make only transient
contact with the participants (that is a clinical relationship
is not established or intended) and because risk is gener-
ally low, relying on the prevailing standard of health care
in the areas may be appropriate.
Does the absence of adequate medical services imply that
tests in surveys should not be performed? The question
might be reframed, "To what extent is a report of a disease
or condition considered to be a benefit when treatment is
not immediately available?" Risks of knowledge, in and of
itself, may be considered minimal. It can be stated that the
primary purpose of data collected in a national survey is
not to provide benefit at the individual level, but to collect
information to benefit the whole population in the long
term. Thus, a discussion of the benefits from a survey
needs to balance the immediate benefit to participants
and to the nation.
Ethical considerations about beneficence are often mixed
with humanitarian concerns to provide health care serv-
ices to those in need. Historically in the United States the
consideration of risks and benefits of most surveys has not
lead to recommends that require that health care be pro-
vided to survey participants. The health care needs of par-
ticipants and their communities fuels considerations to
use survey work as a vehicle to provide care. The doctors
or nurses on the survey team may be the only health care
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professional that is actually available in a resource poor
setting. However, building a transient health care provi-
sion system onto a survey can not take the place of
national health care system development. In addition,
ethical considerations about coercion or inducements
must be considered. Survey participation should not be
perceived by the participants as a criterion for receiving
services.
Special considerations for HIV testing
HIV testing in national population-based surveys in less
developed countries has been successfully completed in a
number of less developed countries [4,5,24]. The inclu-
sion of HIV as a biomarker requires special consideration
because of the stigma attached to the disease and the life
threatening nature of the disease. Disclosure of HIV status
is a life and death issue in some countries making the
standards for confidentiality in such surveys very high.
Confidentiality must be maintained in the field (protec-
tion of disclosure to family and neighbors in communi-
ties) and in data sets (protection of survey participants
from use of the data set to identify HIV positive individu-
als). The burden of maintaining confidentiality among
field staff members in the context of rapid testing in the
field is a real concern. In a number of research protocols,
it would be important to debate the obligation to report
the finding if the researchers can know the HIV status of a
person in a study.
De-linked protocols ensure the confidentiality of the data,
but disappoint advocates of voluntary counseling and
testing (VCT) who look at reporting results to survey par-
ticipants as a service. Indeed, HIV test results (received
voluntarily) can be considered as a public health good
and as a benefit to the individual. Reconciliation of needs
for confidentiality and service has been found in the pro-
vision of VCT services in conjunction with surveys that
collect de-linked data. This necessitates repeat testing of
those who want to know their HIV status.
III. Discussion and recommendations
This discussion of the ethics related to the incorporation
of biomarkers into population-based surveys is a starting
point for agencies conducting health surveys in less devel-
oped countries and those providing technical assistance
and funding. Institutional responses to ethical conduct of
science in less developed countries have been emphasized
here and this institutional capacity should be considered
integral to the capacity building in health that is sup-
ported by many international donor agencies. Developing
countries must have their own sustainable institutional
frameworks to discuss, develop, and implement ethical
protections which are morally sound and nationally rele-
vant [25]. International harmonization of ethical princi-
ples and procedures as they relate to population-based
surveys using biomarkers need to be established. A set of
standards for ethical practice may be preferable to the
development of different standards for developed and less
developed settings. Current practices in use may be appro-
priate but need to be explicitly discussed and debated for
adoption in less developed settings. While implementa-
tion of surveys will differ in various countries, the princi-
ples underlying their conduct should not differ. Ethical
issues raised by population-based surveys are distinct
from those raised by clinical research. Defining the benefit
of survey work to participants needs to be made explicit
but the mission of a survey should not be confused with a
clinical mission. At the same time, the knowledge or spe-
cific information a sample person learns about their
health status should not be considered an inducement for
survey participation.
Development of capacity for ethical review of survey
research in less developed countries should be a part of
technical assistance from high income countries. While
ethical principles may be global, procedures must be
adapted to local conditions, and local IRBs must be able
to ensure that ethical principles are translated into imple-
mentation plans. Survey activities would be well served by
the development of more sophisticated Institutional
Review Boards in host countries that undertake survey
work. Development agencies and their contractors may
wish to invest in this development, and capacity building
in the health sector should formally include work in this
area. The composition of IRBs should also include those
who understand the technical aspects of survey work, as
the particulars of research are essential in the appropriate
evaluation of ethical procedures and standards.
Population-based surveys frequently have political conse-
quences that must be anticipated by donors and host
countries. While these considerations are important, they
should not become confused with the ethical standards
that frame survey design. The institutional integrity of
IRBs in donor and in host-recipient countries is essential.
The power differential between donor and host institu-
tions must be recognized when institutional rules are
established. A practical recommendation is for the cost of
the ethical review to be borne by the research partner from
the high income country as part of the technical assistance
offered in a particular research project. Studies funded by
rich countries should fund ethical review of surveys in
poor countries in such a way that level of functioning and
autonomy of local IRBs (Institutional Review Boards) can
be ensured.
International donor agencies should facilitate collection
of research experience and dissemination of such experi-
ence. An exploration of such practices can be done to
establish contemporary practices. The National Center for
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Health Statistics of the Centers for Disease Control and
Prevention (CDC) has conducted the National Health
and Nutrition Examination Survey (NHANES) in the
United States for over 30 years. The written policies and
procedures of the NHANES http://www.cdc.gov/nchs rep-
resent the standard for the use of health assessments in
population-based surveys in the United States.
Because many biological specimens can be used for
genetic testing, specimens being collected in less devel-
oped countries will draw great interest. One practical rec-
ommendation to address this inevitability is to follow the
approach that is being used in the United States that has
allowed provisional use of samples for genetic testing in
an exploratory setting under on-going scrutiny of an IRB.
This proposed exploratory study of ethical standards
should be well supervised and well staffed by IRBs in both
the donor country and in the host country. A well con-
ducted study will maximize the learning concerning ethi-
cal standards for genetic testing and safe guard the rights
of the sample persons. IRBs should require intimate
involvement in such exploratory work with frequent
reporting back to evaluate the practical issues raised by
genetic testing. Who owns genetic materials once it is col-
lected is a unique issue that must be addressed. Experience
with genetic testing in less developed countries may have
implication for a discussion that is increasingly global in
nature.
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